Evidence map›Paper›PMID 30487653›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2019

Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder.

Michael J McCarthy, Heather Wei, Caroline M Nievergelt, Andrea Stautland, Adam X Maihofer, David K Welsh, Paul Shilling, Martin Alda, Ney Alliey-Rodriguez, Amit Anand and 52 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Change in circadian preference predicts sustained treatment outcomes in patients with unipolar depression and evening preference.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. The Mechanisms of Lithium Action: The Old and New Findings.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. The sleep-circadian interface: A window into mental disorders.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Review
  18. Review
  19. Article
  20. Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

62 authors at 19 institutions in 3 countries.

Michael J McCarthyDepartment of Psychiatry and Center for Circadian Biology, University of California, San Diego, 3350 La Jolla Village Dr. MC 116A, San Diego, CA, 92161, USA. mmccarthy@ucsd.edu.ORCID http://orcid.org/0000-0001-6219-4945
Heather WeiPsychiatry Service, VA San Diego Healthcare, San Diego, CA, 92161, USA.
Caroline M NievergeltDepartment of Psychiatry and Center for Circadian Biology, University of California, San Diego, 3350 La Jolla Village Dr. MC 116A, San Diego, CA, 92161, USA.ORCID http://orcid.org/0000-0001-5766-8923
Andrea StautlandDepartment of Clinical Medicine, Section for Psychiatry, University of Bergen, Bergen, Norway.
Adam X MaihoferDepartment of Psychiatry and Center for Circadian Biology, University of California, San Diego, 3350 La Jolla Village Dr. MC 116A, San Diego, CA, 92161, USA.ORCID http://orcid.org/0000-0003-4517-1623
David K WelshDepartment of Psychiatry and Center for Circadian Biology, University of California, San Diego, 3350 La Jolla Village Dr. MC 116A, San Diego, CA, 92161, USA.
Paul ShillingDepartment of Psychiatry and Center for Circadian Biology, University of California, San Diego, 3350 La Jolla Village Dr. MC 116A, San Diego, CA, 92161, USA.
Martin AldaDepartment of Psychiatry, Dalhousie University, Halifax, Canada.
Ney Alliey-RodriguezDepartment of Psychiatry, University of Chicago, Chicago, USA.ORCID http://orcid.org/0000-0001-8594-5676
Amit AnandDepartment of Psychiatry, Indiana University, Bloomington, USA.
Ole A AndreassonJebsen Centre for Psychosis Research, University of Oslo, Oslo, Norway.
Yokesh BalaramanDepartment of Psychiatry, Indiana University, Bloomington, USA.
Wade H BerrettiniDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Holli BertramDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Kristen J BrennandDepartments of Neuroscience and Psychiatry, Icahn School of Medicine at Mt Sinai, New York, USA.ORCID http://orcid.org/0000-0003-0993-5956
Joseph R CalabreseDepartment of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Cynthia V CalkinDepartment of Psychiatry, Dalhousie University, Halifax, Canada.
Ana ClaasenNeurogenomics Division, Translational Genomics Research Institute, Phoenix, USA.ORCID http://orcid.org/0000-0003-2069-2457
Clara ConroyDepartment of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
William H CoryellDepartment of Psychiatry, University of Iowa, Iowa City, USA.
David W CraigNeurogenomics Division, Translational Genomics Research Institute, Phoenix, USA.
Nicole D'ArcangeloDepartment of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Anna DemodenaPsychiatry Service, VA San Diego Healthcare, San Diego, CA, 92161, USA.
Srdjan DjurovicJebsen Centre for Psychosis Research, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-8140-8061
Scott FeederDepartment of Psychiatry, The Mayo Clinic, Rochester, USA.
Carrie FisherDepartment of Psychiatry, Indiana University, Bloomington, USA.
Nicole FrazierDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Mark A FryeDepartment of Psychiatry, The Mayo Clinic, Rochester, USA.
Fred H GageLaboratory of Genetics, Salk Institute for Biological Studies, La Jolla, USA.ORCID http://orcid.org/0000-0002-0938-4106
Keming GaoDepartment of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Julie GarnhamDepartment of Psychiatry, Dalhousie University, Halifax, Canada.
Elliot S GershonDepartment of Psychiatry, University of Chicago, Chicago, USA.ORCID http://orcid.org/0000-0003-4818-8631
Kara GlazerDepartment of Psychiatry, Johns Hopkins University, Baltimore, USA.
Fernando GoesDepartment of Psychiatry, Johns Hopkins University, Baltimore, USA.
Toyomi GotoDepartment of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Gloria HarringtonDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Petter JakobsenNorment and KG Jebsen Centre for Neuropsychiatry, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Masoud KamaliDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Elizabeth KarbergDepartment of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Marisa KellyDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-7151-1938
Susan G LeckbandPsychiatry Service, VA San Diego Healthcare, San Diego, CA, 92161, USA.
Falk LohoffDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Melvin G McInnisDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-0375-6247
Francis MondimoreDepartment of Psychiatry, Johns Hopkins University, Baltimore, USA.
Gunnar MorkenDivision of Psychiatry, St. Olav University Hospital of Trondheim and Department of Mental Health Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.ORCID http://orcid.org/0000-0003-1972-5901
John I NurnbergerDepartment of Psychiatry, Indiana University, Bloomington, USA.
Sarah ObralDepartment of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Ketil J OedegaardDepartment of Clinical Medicine, Section for Psychiatry, University of Bergen, Bergen, Norway.
Abigail OrtizDepartment of Psychiatry, University of Ottawa, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0001-6886-767X
Megan RitcheyDepartment of Psychiatry, Johns Hopkins University, Baltimore, USA.
Kelly RyanDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Martha SchinagleDepartment of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Helle SchoeyenDepartment of Clinical Medicine, Section for Psychiatry, University of Bergen, Bergen, Norway.
Candice SchwebelDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Martha ShawDepartment of Psychiatry, University of Chicago, Chicago, USA.
Tatyana ShekhtmanDepartment of Psychiatry and Center for Circadian Biology, University of California, San Diego, 3350 La Jolla Village Dr. MC 116A, San Diego, CA, 92161, USA.
Claire SlaneyDepartment of Psychiatry, Dalhousie University, Halifax, Canada.
Emma StappDepartment of Psychiatry, Johns Hopkins University, Baltimore, USA.ORCID http://orcid.org/0000-0003-0628-0704
Szabolcs SzelingerNeurogenomics Division, Translational Genomics Research Institute, Phoenix, USA.
Bruce TarwaterNeurogenomics Division, Translational Genomics Research Institute, Phoenix, USA.
Peter P ZandiDepartment of Psychiatry, Johns Hopkins University, Baltimore, USA.
John R KelsoeDepartment of Psychiatry and Center for Circadian Biology, University of California, San Diego, 3350 La Jolla Village Dr. MC 116A, San Diego, CA, 92161, USA.
Case Western Reserve University · USUniversity of California San Diego · USUniversity of Michigan · USJohns Hopkins University · USDalhousie University · CAIndiana University Bloomington · USTranslational Genomics Research Institute · USUniversity of Chicago · USUniversity of Pennsylvania · USVA San Diego Healthcare System · USHaukeland University Hospital · NOMayo Clinic · USUniversity of Bergen · NOUniversity of Oslo · NOIcahn School of Medicine at Mount Sinai · USNorwegian University of Science and Technology · NOSalk Institute for Biological Studies · USUniversity of Iowa · USUniversity of Ottawa · CA

Funding

Clinical Genomics and Experimental TherapeuticsZIAAA000242 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI LOHOFF, FALK · 2015 to 2025
$26.7M
Pharmacogenomics of Mood Stabilizer Response in Bipolar DisorderU01MH092758 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KELSOE, JOHN R. · 2010 to 2014
$6.2M
Cellular Circadian Clocks in Mood DisordersI01BX001146 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI WELSH, DAVID K · 2012 to 2020
–
Circadian Rhythms in Neuronal Models of Bipolar DisorderI01BX003431 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI MCCARTHY, MICHAEL JOSEPH · 2017 to 2025
–
BLRD VA I01 BX001146BLRD VA I01 BX003431NIMH NIH HHS U01 MH092758U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH92758U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) U01MH092758
6 · The paper itself

Abstract

Bipolar disorder (BD) is a serious mood disorder associated with circadian rhythm abnormalities. Risk for BD is genetically encoded and overlaps with systems that maintain circadian rhythms. Lithium is an effective mood stabilizer treatment for BD, but only a minority of patients fully respond to monotherapy. Presently, we hypothesized that lithium-responsive BD patients (Li-R) would show characteristic differences in chronotype and cellular circadian rhythms compared to lithium non-responders (Li-NR). Selecting patients from a prospective, multi-center, clinical trial of lithium monotherapy, we examined morning vs. evening preference (chronotype) as a dimension of circadian rhythm function in 193 Li-R and Li-NR BD patients. From a subset of 59 patient donors, we measured circadian rhythms in skin fibroblasts longitudinally over 5 days using a bioluminescent reporter (Per2-luc). We then estimated circadian rhythm parameters (amplitude, period, phase) and the pharmacological effects of lithium on rhythms in cells from Li-R and Li-NR donors. Compared to Li-NRs, Li-Rs showed a difference in chronotype, with higher levels of morningness. Evening chronotype was associated with increased mood symptoms at baseline, including depression, mania, and insomnia. Cells from Li-Rs were more likely to exhibit a short circadian period, a linear relationship between period and phase, and period shortening effects of lithium. Common genetic variation in the IP

Indexed as

Circadian RhythmFibroblastsAdultAnimalsAntimanic AgentsBipolar DisorderCells, CulturedGenotyping TechniquesHumansInositol 1,4,5-Trisphosphate ReceptorsLithium CompoundsLuminescent MeasurementsMiceNIH 3T3 CellsPeriod Circadian ProteinsPolymorphism, Single NucleotideAntimanic AgentsInositol 1,4,5-Trisphosphate ReceptorsITPR3 protein, mouseLithium CompoundsPer2 protein, mousePeriod Circadian Proteins

Identifiers

PMID30487653
PMCPMC6333516
OpenAlexW2900996428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.